ICU Medical Voluntarily Recalls Lots of Potassium Chloride Injection Bags
Recently, ICU Medical, Inc. voluntarily recalled certain lots of potassium chloride injection bags with overwrap labels. This came after a customer complaint was received that Potassium Chloride Inj. Bags that had overlap labels of 20 mEq, which incorrectly identify the bag as Potassium Chloride Inj. 10mEq. This mislabeling has the potential to cause harm. If you were harmed due to improperly labeled potassium chloride, you should call the seasoned Chicago-based lawyers of Moll La Group to determine your legal options. Billions have been recovered in cases with which we’ve been involved around the country.
Contact Moll Law Group About a Potassium Chloride Claim
The manufacturer has recalled certain batches of Potassium Chloride due to the possibility of mislabeling on product overwraps so that certain units are identified as 10 mEq instead of 20 mEq. When that incorrect overwrap is in place, the correct 20 mEq label fixed to the bag can’t be seen easily. This can cause serious problems.
If a health care provider calculates the patient’s dose of the medication using the 10mEq label, the patient will get an intravenous overdose of potassium chloride. This can lead to problems like death from cardiac arrest, dysrhythmias, hypotension, confusion, and neuromuscular dysfunction such as ascending paralysis, vertigo, mental confusion and vertigo. Various groups are at real risk for adverse or even fatal consequences; these groups include premature infants, patients who have had cardiac arrhythmia, patients who have had chronic renal insufficiency or acute renal failure, and patients on chronic parenteral nutrition. However, it should be noted that there haven’t been reports of adverse events due to the mislabeling thus far.
Illinois Injury and Mass Tort Lawyer Blog





4, the Chicago-based company Riverside Natural Foods
A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC
Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer’s. Unfortunately, it also appears that one of the drugs’ potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (
In February, the Food and Drug Administration (FDA) announced that it is
Red No. 3 is used as bright red artificial coloring in candy, cereal, fruit cocktails, strawberry-flavored milkshakes, and other foods and beverages. It’s ubiquitous. And so it’s alarming that data has surfaced that the dye can cause cancer in lab animals; specifically, evidence reveals that lab male rats exposed to heightened
2025 opened with announcements from the U.S. Food and Drug Administration (FDA) about cessation of smoking and the reduction of nicotine addiction. The first of the two announcements was a Notice of Proposed Rulemaking. This would call for a reduction in nicotine in combustible tobacco products to levels that are not addictive. This has been requested by public health advocates since 2009’s Family Smoking Prevention and Tobacco Control Act, which authorized such a change. The agency has set out a comment period that from January 16 all the way to September 15 of this year. However, the other announcement had to do with authorizing 3 mg and 6 mg nicotine content in a
In an important legal step, the Depo-Provera birth control lawsuits have been centralized and transferred to
Last July, Boar’s Head
This year, important actions will occur in a number of federal